why choose us

First received: June 10, 2024

Clinical Trial: Biochemical Role of Long Non-coding RNA MALAT 1 and Serum Tumor Necrosis Factor Alpha in Bronchial Asthma Patients.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Bronchial Asthma

Study Type: OBSERVATIONAL


Official Title: Biochemical Role of Long Non-coding RNA MALAT 1 and Serum Tumor Necrosis Factor Alpha in Bronchial Asthma Patients.

Brief Summary: Bronchial asthma affects more than a quarter of a billion people worldwide.It is responsible for over 1000 deaths a day, of which the majority are preventable (Levy, 2015).Asthma is a common heterogeneous disease characterized by chronic airway inflammation.It is defined by the history of variable respiratory symptoms, such as shortness of breath, chest tightness, wheezes, and cough, together with variable expiratory airflow limitation.Airflow limitation may later become persistent (GINA, 2023).The diagnosis of…

Read more